Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)

Name: Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)
Published: 2018
License: Public Domain

Merck Sharp & Dohme LLC · 2018

ClinicalTrials.gov · Datasets · License: Public Domain · 2018

Open Source ↗

head-and-neck-neoplasms

head and neck neoplasms, programmed cell death 1 (pd1, pd-1), programmed cell death 1 ligand 1 (pdl1, pd-l1), programmed cell death 1 ligand 2 (pdl2, pd-l2), interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)

Related documents